...
首页> 外文期刊>European journal of pharmaceutical sciences >Pluronic-g-poly(acrylic acid) copolymers as novel excipients for site specific, sustained release tablets.
【24h】

Pluronic-g-poly(acrylic acid) copolymers as novel excipients for site specific, sustained release tablets.

机译:Pluronic-g-poly(丙烯酸)共聚物是用于定点缓释片剂的新型赋形剂。

获取原文
获取原文并翻译 | 示例
           

摘要

Potential utility of copolymers comprising Pluronic((R)) (PEO-PPO-PEO) surfactants covalently conjugated with poly(acrylic acid) (PAA) as excipients for sustained-release tablets was explored. Apparent particle density, particle size distribution, Carr index, thermal stability, and compression behavior of the Pluronic-PAA copolymers were characterized. Tablets prepared by direct compression of blends of Pluronic-PAA copolymers were evaluated on the basis of their thermomechanical profile, crushing strength, friability, and drug release properties. Small molecular weight drugs of aqueous solubility decreasing in the order theophylline>hydrochlorothiazide>nitrofurantoin were incorporated to the tablets. For comparison purposes, tablets were also prepared from PAA of Carbopol((R)) 71G (C71G), and mixtures of C71G and Pluronic((R)) F127, with each of the above three drugs. The Pluronic-PAA aggregates are stabilized by hydrophobic associations between poly(propylene oxide) (PPO) segments in aqueous solutions, and thus require higher ionization of the carboxylic groups to overcome the associations and swell. The swelling pattern of the Pluronic-PAA copolymers is more dramatically pH-dependent than that of Carbopol lacking any hydrophobic associations. The drug retention in and release from the Pluronic-PAA based tablets is profoundly pH-dependent and hence specific to the pH exceeding that of the pK(a)>5 of these copolymers. Theophylline- and hydrochlorotiazide-containing tablets made with Pluronic-PAA copolymers showed a reduced release rate under acidic conditions compared to the neutral or alkaline conditions, while the opposite pattern was observed with the Carbopol-based tablets due to the different pH-dependent swelling behavior of the polymers. Nitrofurantoin-containing tablets showed a remarkably low drug release rate owing to the strong hydrophobic character of nitrofurantoin and of its complexes with the copolymers. Integrity of the nitrofurantoin-containing tablets was maintained during the 24h release test. Zero-order kinetics of the cumulative release profile of all drugs under study was observed with the Pluronic-PAA as a tablet excipient. Adequate mechanical properties, the self-assembling behavior, and the pH-sensitiveness of the Pluronic-PAA copolymers make them promising excipients for tablets with preferential delivery into a neutral to alkaline pH environment.
机译:探索了包含与聚丙烯酸(PAA)共价共轭的Pluronic(PEO-PPO-PEO)表面活性剂作为缓释片剂赋形剂的共聚物的潜在用途。表征了Pluronic-PAA共聚物的表观颗粒密度,粒度分布,Carr指数,热稳定性和压缩行为。通过直接压缩Pluronic-PAA共聚物的共混物制得的片剂,根据其热机械特性,抗碎强度,脆碎性和药物释放特性进行了评估。将水溶性降低的小分子量药物按照茶碱>氢氯噻嗪>硝基呋喃妥因的顺序加入。为了进行比较,还从Carbopol 71G(C71G)的PAA以及C71G和Pluronic F127的混合物与上述三种药物中的每一种制备片剂。 Pluronic-PAA聚集体通过水溶液中聚环氧丙烷(PPO)片段之间的疏水缔合而稳定,因此需要更高的羧基电离度以克服缔合和溶胀。与没有任何疏水性缔合的Carbopol相比,Pluronic-PAA共聚物的膨胀模式对pH的依赖性更大。药物在基于Pluronic-PAA的片剂中的保留和释放与pH密切相关,因此对超过这些共聚物的pK(a)> 5的pH特定于pH。与中性或碱性条件相比,用Pluronic-PAA共聚物制备的含茶碱和氢氯噻嗪的片剂在酸性条件下的释放速率降低,而基于Carbopol的片剂则观察到相反的模式,这是由于pH依赖的溶胀行为不同聚合物。由于硝基呋喃妥因及其与共聚物的复合物具有很强的疏水性,因此含呋喃妥因的片剂显示出非常低的药物释放速率。在24小时释放测试期间,保持了含呋喃妥因的片剂的完整性。使用Pluronic-PAA作为片剂赋形剂,可以观察到所有正在研究的药物的累积释放曲线的零级动力学。 Pluronic-PAA共聚物具有足够的机械性能,自组装性能和pH敏感性,使其成为片剂的有希望的赋形剂,可优先递送至中性至碱性pH环境。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号